QA: Biofrontera Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001858685_2024_Biofrontera_Inc.pdf

Logs

warning Large missing amount for aggregate "Expenses" added to remainder. industry.us_generic {'missing_ratio': 24.84225485551871, 'aggregate_val': 54553000, 'exp_sum': 2111000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'ResearchAndDevelopmentExpense': 2089000, 'remainder_Expenses': 22000}}

Graph

Absolute values for 0001858685, Biofrontera Inc

  xvar xval
0 AssetsCurrent 23,075,000
1 IntangibleAssetsNetIncludingGoodwill 2,629,000
2 PropertyPlantAndEquipmentNet 134,000
3 remainder_Assets 2,094,000
4 LiabilitiesCurrent 18,088,000
5 LiabilitiesNoncurrent 841,000
6 remainder_Liabilities 4,210,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 38,975,000
9 ResearchAndDevelopmentExpense 77,000
10 remainder_Expenses 17,710,000
11 remainder_Revenues 34,071,000
12 remainder_NetIncome 2,560,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 27,932,000
1 Liabilities 23,139,000
2 Expenses 56,762,000
3 Revenues 34,071,000
4 StockholdersEquity 4,793,000
5 NetIncome -20,131,000
6 ComprehensiveNetIncome -20,131,000
7 BaseVar 72,232,000
8 EconomicCapitalRatiobeforeLimitedLiability -0.379
9 EconomicCapitalRatio 1.39

Edgar->Model Mapping

Feature Distribution

Change over Time